Modulation of vincristine cytotoxicity by dexverapamil in sensitive and resistant HL-60 cell lines as a function of extracellular protein binding
Stratmann, G.; Harder, S.; Hölzer, D.; Hofmann, W.K.; Ottmann, O.G.; Woodcock, B.G.; Hoffmann, W.K.
International Journal of Clinical Pharmacology and Therapeutics 36(2): 103-106
1998
ISSN/ISBN: 0946-1965 PMID: 9520158 Document Number: 484508
Document emailed within 1 workday
Related Documents
Tew, K.D.; Bomber, A.M.; Hoffman, S.J. 1988: Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines Cancer Research 48(13): 3622-3625Goldenberg, G.J.; Wang, H.; Blair, G.W. 1986: Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia Cancer Research 46(6): 2978-2983
Guo, N.; Zabrenetzky, V.S.; Chandrasekaran, L.; Sipes, J.M.; Lawler, J.; Krutzsch, H.C.; Roberts, D.D. 1998: Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin 1 Cancer Research 58(14): 3154-3162
Jondal, M.; Targan, S. 1978: Spontaneous and lectin-dependent cellular cytotoxicity by lymphocyte subpopulations against cell lines susceptible or resistant to spontaneous cytotoxicity Clinical and Experimental Immunology 33(1): 121-127
Main, E.K.; Monos, D.S.; Lampson, L.A. 1988: IFN-treated neuroblastoma cell lines remain resistant to T cell-mediated allo-killing, and susceptible to non-MHC-restricted cytotoxicity Journal of Immunology 141(9): 2943-2950
Khesin, I.E.; Amchenkova, A.M.; Koz'iakov, S.I. 1971: Basic protein content in reticular cells of transplantable lines, sensitive and resistant to enteroviruses Biulleten' Eksperimental'noi Biologii i Meditsiny 72(11): 116-118
Hussain, S.A.; Marouf, B.H. 2013: Silibinin improves the cytotoxicity of methotrexate in chemo resistant human rhabdomyosarcoma cell lines Saudi Medical Journal 34(11): 1145-1150
Karlsson, K.; Marklund, S.L. 1989: Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells Laboratory Investigation; a Journal of Technical Methods and Pathology 60(5): 659-666
Avramis, I.A.; Kwock, R.; Avramis, V.I. 2001: Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines Anticancer Research 21(4a): 2281-2286
Seidenfeld, J.; Sprague, W.S. 1990: Comparisons between sensitive and resistant human tumor cell lines regarding effects of polyamine depletion on chloroethylnitrosourea efficacy Cancer Research 50(3): 521-526
Calamai, P.; Carotti, S.; Guerri, A.; Mazzei, T.; Messori, L.; Mini, E.; Orioli, P.; Speroni, G.P. 1998: Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin Anti-Cancer Drug Design 13(1): 67-80
Litterst, C.L.; Schweitzer, V.G. 1988: Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity Research Communications in Chemical Pathology and Pharmacology 61(1): 35-48
Gatto, S.; Scappini, B.; Pham, L.; Onida, F.; Milella, M.; Ball, G.; Ricci, C.; Divoky, V.; Verstovsek, S.; Kantarjian, H.M.; Keating, M.J.; Cortes-Franco, J.E.; Beran, M. 2003: The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate Haematologica 88(8): 853-863
Toffoli, G.; Bevilacqua, C.; Franceschin, A.; Boiocchi, M. 1989: Chemosensitivity of drug-sensitive and drug-resistant P388 leukemia cell lines after hyperthermic treatment Journal of ChemoTherapy 1(4 Suppl): 1159-1161
Bergh, J.; Björk, P.; Westlin, J.E.; Nilsson, S. 1988: Expression of an estramustine-binding associated protein in human lung cancer cell lines Cancer Research 48(16): 4615-4619
Saxena, R.K.; Adler, W.H. 1979: Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line Journal of Immunology 123(2): 846-851
Deffie, A.M.; Alam, T.; Seneviratne, C.; Beenken, S.W.; Batra, J.K.; Shea, T.C.; Henner, W.D.; Goldenberg, G.J. 1988: Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia Cancer Research 48(13): 3595-3602
Jiang, Y.; Li, C.; Ma, Y.; Chen, J.; Li, Y.; Chen, L. 2012: The Inhibition of the Pemetrexed-Activated MAPK Pathway via Sorafenib is Involved in the Synergistic Mechanism of Sorafenib Subsequent Potentiation of Pemetrexed Cytotoxicity in EGFR TKI-Resistant Cell Lines Clinical Laboratory 58(5-6): 551-561
Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. 1981: Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Research 41(5): 1967-1972
Mulcahy, R.T.; Siemann, D.W. 1983: In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines Cancer Research 43(10): 4709-4713